Table 1. Baseline characteristics.

		Number of available data
Median age, years (range)	57 (25–82)	67
Male gender, n	36	67
Body mass index, median (range)	23.7 (13.2–33)	64
Performance status (ECOG), n		67
0–1	62
2	5
Functioning tumour, n	38	67
Primary lesion
Pancreatic location, n	19	67
Diameter (cm), median (range)	3 (0.8–16)	51
Resected, n	43	67
Extra-hepatic lesion(s), n	26	67
Indication of treatment, n		67
Progressive disease	41
Aggressive disease	9
Uncontrolled hormone-related symptoms	17
Previous chemotherapy, n	19	67
Concomitant treatment with somatostatin analogs, n	25	67
MIB-1 (%), median (range)	3 (1–60)	34
Radiological features of metastases
Longest diameter (cm), n	4 (1–14)	67
% of liver replaced by metastases, n		67
<25%	29
>25 and <50%	14
>50 and <75%	12
>75%	12
Arterial phase enhancement, n	42	61
Heterogeneous pattern, n	45	62
Cytotoxic agent, n		67
Streptozotocin	44
Doxorubicin	23